Our Team

With over 25 years of experience in preclinical contract research and development services and a significant product development track record, the ImQuest scientific team has extensive expertise in the development of small molecules, natural products, biologics and vaccines for the treatment and prevention of infectious disease, cancer, and inflammatory disease.

We are committed to earning our client’s trust and building long term relationships through collaboration, unwavering commitment to quality science and consistent and effective communication. Our team has decades of experience in the field of virology, microbiology and oncology. As such, we understand that each product and each client is unique and we strive to provide effective solutions. 

ImQuest virology microbiology infectious disease CRO
Robert W. Buckheit Jr., PhD
President and CSO
Tracy Hartman, M.S.
Director
Anti-Infective Services
Karen Buckheit, M.S.
Director
Microbiology and Prevention Services
Guy Pilkington, Ph.D.
Director
Hepatitis and Molecular Viorology Services
Robert W. Buckheit, III Ph.D.
Director
Business Development
Immunology Services
Daniel R. Caffoe
Chairman of the Board